Function of the Th17/interleukin-17A immune response in murine lupus nephritis

Arthritis and Rheumatology

Volumn 67, Issue 2, 2015, Pages 475-487

  Schmidt, Tilman ^a   Paust, Hans Joachim ^a   Krebs, Christian F ^a   Turner, Jan Eric ^a   Kaffke, Anna ^a   Bennstein, Sabrina B ^a   Koyro, Tobias ^a   Peters, Anett ^a   Velden, Joachim ^b   Hünemörder, Stefanie ^a   Haag, Friedrich ^a   Steinmetz, Oliver M ^a   Mittrücker, Hans Willi ^a   Stahl, Rolf A K ^a   Panzer, Ulf ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17C; MESSENGER RNA; ANTIIDIOTYPIC ANTIBODY; CD3 ANTIGEN; GAMMA INTERFERON;

ALBUMINURIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACKCROSSING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOPATHOGENESIS; KIDNEY INJURY; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD3; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-17; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED MRL LPR; MICE, INBRED NZB; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TH17 CELLS;

EID: 84922774529     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38955     Document Type: Article

References (45)

1. Rahman A, Isenberg DA,. Systemic lupus erythematosus [review]. N Engl J Med 2008; 358: 929-39.
2. Anders HJ, Appel GB,. Lupus nephritis: implications of the new ACR lupus nephritis guidelines [review]. Nat Rev Nephrol 2012; 8: 500-1.
3. Bomback AS, Appel GB,. Updates on the treatment of lupus nephritis [review]. J Am Soc Nephrol 2010; 21: 2028-35.
4. Bagavant H, Fu SM,. Pathogenesis of kidney disease in systemic lupus erythematosus [review]. Curr Opin Rheumatol 2009; 21: 489-94.
5. Okamoto A, Fujio K, Tsuno NH, Takahashi K, Yamamoto K,. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int 2012; 82: 969-79.
6. Tipping PG, Holdsworth SR,. T Cells in crescentic glomerulonephritis [review]. J Am Soc Nephrol 2006; 17: 1253-63.
7. Haas C, Ryffel B, Le Hir M,. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 1997; 158: 5484-91.
8. lpr mice. J Immunol 1998; 161: 494-503.
9. lpr mice delays nephritis and intrarenal IFN-γ expression, and diminishes systemic pathology. J Immunol 2003; 170: 3915-25.
10. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW,. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008; 127: 385-93.
11. Crispin JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-6.
12. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC,. IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol 2010; 184: 4605-9.
13. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 2012; 37: 1104-15.
14. Toussirot E,. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases [review]. Inflamm Allergy Drug Targets 2012; 11: 159-68.
15. Jones SA, Sutton CE, Cua D, Mills KH,. Therapeutic potential of targeting IL-17. Nat Immunol 2012; 13: 1022-5.
16. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001; 12: 1369-82.
17. Davidson A,. Lupus nephritis: lessons from murine models [review]. Nat Rev Rheumatol 2010; 6: 13-20.
18. Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, et al. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003; 171: 489-97.
19. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G,. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25: 6-12.
20. Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, et al. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 2012; 82: 72-83.
21. Uyttenhove C, Van Snick J,. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 2006; 36: 2868-74.
22. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol 2009; 183: 4693-704.
23. Turner JE, Paust HJ, Bennstein SB, Bramke P, Krebs C, Steinmetz OM, et al. Protective role for CCR5 in murine lupus nephritis. Am J Physiol Renal Physiol 2012; 302: F1503-15.
24. Turner JE, Krebs C, Tittel AP, Paust HJ, Meyer-Schwesinger C, Bennstein SB, et al. IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN. J Am Soc Nephrol 2012; 23: 1486-95.
25. Kurts C, Panzer U, Anders HJ, Rees AJ,. The immune system and kidney disease: basic concepts and clinical implications [review]. Nat Rev Immunol 2013; 13: 738-53.
26. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-41.
27. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-32.
28. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-8.
29. Ambrosi A, Espinosa A, Wahren-Herlenius M,. IL-17: a new actor in IFN-driven systemic autoimmune diseases [review]. Eur J Immunol 2012; 42: 2274-84.
30. Geremia A, Jewell DP,. The IL-23/IL-17 pathway in inflammatory bowel disease [review]. Expert Rev Gastroenterol Hepatol 2012; 6: 223-37.
31. Ariza ME, Williams MV, Wong HK,. Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application [review]. Clin Immunol 2013; 146: 131-9.
32. Turner JE, Paust HJ, Steinmetz OM, Panzer U,. The Th17 immune response in renal inflammation [review]. Kidney Int 2010; 77: 1070-5.
33. Apostolidis SA, Crispin JC, Tsokos GC,. IL-17-producing T cells in lupus nephritis [review]. Lupus 2011; 20: 120-4.
34. Kitching AR, Holdsworth SR,. The emergence of Th17 cells as effectors of renal injury. J Am Soc Nephrol 2011; 22: 235-8.
35. Wong CK, Ho CY, Li EK, Lam CW,. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589-93.
36. Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP, Wang GH, et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 2010; 37: 81-5.
37. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009; 10: 778-85.
38. Zhang Z, Kyttaris VC, Tsokos GC,. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009; 183: 3160-9.
39. Odobasic D, Gan PY, Summers SA, Semple TJ, Muljadi RC, Iwakura Y, et al. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am J Pathol 2011; 179: 1188-98.
40. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-25.
41. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-98.
42. H17 cells towards commensal bacterial antigens. Nature 2014; 510: 152-6.
43. H17 immune response and tissue injury in experimental crescentic GN. J Am Soc Nephrol 2013; 24: 1955-65.
44. H17-mediated GN. J Am Soc Nephrol 2014. E-pub ahead of print.
45. Amarilyo G, Lourenco EV, Shi FD, La Cava A,. IL-17 promotes murine lupus. J Immunol 2014; 193: 540-3.